Rachel J Bubik

5PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 02, 2025
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia.

Rachel J Bailen, Monica I Aasum, Linda M Tamminga

|Dec 10, 2024
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.

Paul J Hampel, Kari G Rabe, Yucai Wang

|Aug 19, 2021
Malignancy among adult heart transplant recipients following patient-tailored dosing of anti-thymocyte globulin: a retrospective, nested case-control study of individualized dosing.

Rachel J Bubik, Ross A Dierkhising, Kristin C Mara

|Mar 18, 2021
Ideal Body Weight-Based Dosing of Rabbit Antithymocyte Globulin for Cost Minimization in Kidney Transplantation.

Rachel J Bubik, Kristen T Peterson, Laura J Myhre

|Mar 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.

Rachel J Bubik, Dylan M Barth, Christopher Hook

Pageof 1

Frequent Collaborators

2 joint publications

Kari G Rabe

1 joint publications

Paul J Hampel

1 joint publications

Yucai Wang

1 joint publications

Saad S Kenderian